Position
Forefront Analytics, LLC in Bicycle Therapeutics Plc
Back to the book · All holders of BCYC
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$32.6K$7.08 → $4.64
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 13.4K | $94.7K | — | — | — | 0.1% |
| Q1 2026 | 14.4K | $66.8K | $4.64 | −$32.6K | $4.75K | 0.1% |